383 related articles for article (PubMed ID: 3259929)
1. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
2. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
[TBL] [Abstract][Full Text] [Related]
3. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
4. Human blood platelets possess specific binding sites for C1q.
Peerschke EI; Ghebrehiwet B
J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
[TBL] [Abstract][Full Text] [Related]
5. Effects of soluble aggregates of IgG on the binding, uptake and degradation of the C1q subcomponent of complement by adherent guinea pig peritoneal macrophages.
Veerhuis R; Van Es LA; Daha MR
Eur J Immunol; 1985 Sep; 15(9):881-7. PubMed ID: 3876223
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR).
Ghebrehiwet B
J Immunol; 1986 Jul; 137(2):618-24. PubMed ID: 3487576
[TBL] [Abstract][Full Text] [Related]
7. The effect of fibronectin on the processing of C1q- and C3b/bi-coated immune complexes by peripheral blood monocytes.
Sorvillo JM; Gigli I; Pearlstein E
J Immunol; 1986 Feb; 136(3):1023-6. PubMed ID: 3484498
[TBL] [Abstract][Full Text] [Related]
8. Chemistry and molecular genetics of C1q.
Reid KB
Behring Inst Mitt; 1989 Jul; (84):8-19. PubMed ID: 2679537
[TBL] [Abstract][Full Text] [Related]
9. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
10. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
Peerschke EI; Ghebrehiwet B
Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
[TBL] [Abstract][Full Text] [Related]
11. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
12. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
13. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the function of the first component of complement by human C1q receptor.
van den Berg RH; Faber-Krol M; van Es LA; Daha MR
Eur J Immunol; 1995 Aug; 25(8):2206-10. PubMed ID: 7664783
[TBL] [Abstract][Full Text] [Related]
15. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
16. C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors.
Khalkhali-Ellis Z; Bulla GA; Schlesinger LS; Kirschmann DA; Moore TL; Hendrix MJ
J Immunol; 1999 Oct; 163(8):4612-20. PubMed ID: 10510406
[TBL] [Abstract][Full Text] [Related]
17. Effect of complement binding on a solid-phase immunometric TSH assay.
Käpyaho K; Tanner P; Weber T
Scand J Clin Lab Invest; 1989 May; 49(3):211-5. PubMed ID: 2662381
[TBL] [Abstract][Full Text] [Related]
18. Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.
Bobak DA; Frank MM; Tenner AJ
J Immunol; 1986 Jun; 136(12):4604-10. PubMed ID: 3486907
[TBL] [Abstract][Full Text] [Related]
19. C1q inhibits the expression of B lymphoblastoid cell line interleukin 1 (IL 1).
Habicht GS; Beck G; Ghebrehiwet B
J Immunol; 1987 Apr; 138(8):2593-7. PubMed ID: 3494080
[TBL] [Abstract][Full Text] [Related]
20. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
